Now slightly below 50ma on daily.
Likely close above 10ma on weekly.
Looks like they got a catalyst. an upgrade to buy and a price target of 15$, which is a big upside...
Galera Therapeutics shares are trading higher after multiple firms upgraded the stock with bullish ratings and price targets, respectively. (benziga)
maybe when you get more analytical later, then you can distinguish between recent and less than recent catalysts...
No comments:
Post a Comment